LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K183266
    Device Name
    EP-TRACER System
    Manufacturer
    Schwarzer CardioTek GmbH
    Date Cleared
    2019-03-01

    (98 days)

    Product Code
    DQK,DOK
    Regulation Number
    870.1425
    Type
    Special
    Panel
    Cardiovascular
    Reference & Predicate Devices
    K161245
    Predicate For
    K220306
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The EP-TRACER System is an electrophysiology measurement system used to acquire, filter, digitize, amplify, display, and record signals obtained during electrophysiological studies and related procedures.

    The system allows the user to monitor, display and record the signals. The system incorporates a stimulator intended to be used for diagnostic cardiac stimulation during electrophysiological testing of the heart.

    Device Description

    The EP-TRACER system is a computerized electrophysiology measurement system designed for both regular and experimental EP studies.

    The EP-TRACER is comprised of these major components:
    EP-TRACER hardware – Amplifier/stimulator
    EP-TRACER Software – Software pre-installed

    AI/ML Overview

    This document describes the EP-TRACER System V2.2, an electrophysiology measurement system. The FDA 510(k) clearance (K183266) states its substantial equivalence to the predicate device, EP-TRACER System V2.0 (K161245). This submission primarily focuses on software modifications affecting the user interface, with no changes to the hardware.

    Here's an analysis of the acceptance criteria and the study information provided:

    1. Table of Acceptance Criteria and Reported Device Performance

    The provided document does not explicitly state "acceptance criteria" in a quantitative, measurable format like sensitivity/specificity thresholds for a diagnostic device. Instead, the "acceptance criteria" for this submission are implicitly defined by demonstrating that the modifications to the device (V2.2 compared to V2.0) do not adversely affect safety and effectiveness and that the device conforms to relevant harmonized standards.

    The "device performance" is therefore described by showing that the new device (V2.2) maintains the same fundamental technological characteristics and meets all applicable standards as the predicate device (V2.0).

    Characteristic / Acceptance Criteria TypePredicate Device EP-TRACER V2.0 Performance (Implicit Acceptance Baseline)New Device EP-TRACER V2.2 Performance (Reported)Met?
    Hardware ComponentsSame as listed in "Technological Characteristics" tableSameYes
    Amplifier Dimensions38 channels: 28x27x7 cm; 70/102 channels: 28x27x12 cmSameYes
    Environmental Specs (Temp, Humidity)Operating: +10°C to +30°C, 20-80% rH; Storage: -29°C to +66°C, 100 dB, 20 MΩ,
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1